A re-evaluation of anti-NA-14 antibodies in patients with primary Sjögren’s syndrome: Significant role of interferon-γ in the production of autoantibodies against NA-14

References

• Papiris, S. A., I. A. Tsonis, and H. M. Moutsopoulos. 2007. Sjögren’s syndrome. Semin. Respir. Crit. Care Med. 28: 459–471
   PubMed Web of Science ®Google Scholar
• Fox, R. I. 2005. Sjögren’s syndrome. Lancet. 366: 321–331
   PubMed Web of Science ®Google Scholar
• Tan, E. M. 1991. Autoantibodies in pathology and cell biology. Cell. 67: 841–842
   PubMed Web of Science ®Google Scholar
• von Mühlen, C. A., and E. M. Tan. 1995. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin. Arthritis Rheum. 24: 323–358
   PubMed Web of Science ®Google Scholar
• Scofield, R. H. 2004. Autoantibodies as predictors of disease. Lancet. 363: 1544–1546
   PubMed Web of Science ®Google Scholar
• Bizzaro, N., R. Tozzoli, and Y. Shoenfeld. 2007. Are we at a stage to predict autoimmune rheumatic diseases? Arthritis Rheum. 56: 1736–1744
   PubMed Web of Science ®Google Scholar
• Shoenfeld, Y., and A. Tincani. 2005. Autoantibodies-the smoke and the fire. Autoimmunity. 38: 1–2
   PubMed Web of Science ®Google Scholar
• Chan, E. K. L., and L. E. C. Andrade. 1992. Antinuclear antibodies in Sjogren’s syndrome. Rheum. Dis. Clin. North Am. 18: 551–570
   PubMed Web of Science ®Google Scholar
• Vitali, C., S. Bombardieri, R. Jonsson, et al. 2002. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 61: 554–558
   PubMed Web of Science ®Google Scholar
• Haneji, N., T. Nakamura, K. Takio, et al. 1997. Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren’s syndrome. Science. 276: 604–607
   PubMed Web of Science ®Google Scholar
• Waterman, S. A., T. P. Gordon, and M. Rischmueller. 2000. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren’s syndrome. Arthritis Rheum. 43: 1647–1654
   PubMed Web of Science ®Google Scholar
• Robinson, C. P., J. Brayer, S. Yamachika, et al. 1998. Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren’s syndrome. Proc. Natl. Acad. Sci. U. S. A. 95: 7538–7543
   PubMed Web of Science ®Google Scholar
• Andrade, L. E. C., E. K. Chan, C. L. Peebles, and E. M. Tan. 1996. Two major autoantigen-antibody systems of the mitotic spindle apparatus. Arthritis Rheum. 39: 1643–1653
   PubMed Web of Science ®Google Scholar
• Price, C. M., G. A. McCarty, and D. E. Pettijohn. 1984. NuMA protein is a human autoantigen. Arthritis Rheum. 27: 774–779
   PubMed Web of Science ®Google Scholar
• Nozawa, K., M. J. Fritzler, and E. K. Chan. 2005. Unique and shared features of Golgi complex autoantigens. Autoimmun. Rev. 4: 35–41
   PubMed Web of Science ®Google Scholar
• Yamanaka, H., E. H. Willis, C. A. Penning, et al. 1987. Human autoantibodies to poly(adenosine diphosphate-ribose) polymerase. J. Clin. Invest. 80: 900–904
   PubMed Web of Science ®Google Scholar
• Imai, H., M. J. Fritzler, R. Neri, et al. 1994. Immunocytochemical characterization of human NOR-90 (upstream binding factor) and associated antigens reactive with autoimmune sera. Two MR forms of NOR-90/hUBF autoantigens. Mol. Biol. Rep. 19: 115–124
   PubMed Web of Science ®Google Scholar
• Andrade, L. E. C., E. K. Chan, I. Raska, et al. 1991. Human autoantibody to a novel protein of the nuclear coiled body: immunological characterization and cDNA cloning of p80-coilin. J. Exp. Med. 173: 1407–1419
   PubMed Web of Science ®Google Scholar
• Ramos-Morales, F., C. Infante, C. Fedriani, et al. 1998. NA14 is a novel nuclear autoantigen with a coiled-coil domain. J. Biol. Chem. 273: 1634–1639
   PubMed Web of Science ®Google Scholar
• Errico, A., P. Claudiani, M. D’Addio, E. I. Rugarli. 2004. Spastin interacts with the centrosomal protein NA14, and is enriched in the spindle pole, the midbody and the distal axon. Hum. Mol. Genet. 13: 2121–2132
   PubMed Web of Science ®Google Scholar
• Pfannenschmid, F., V. C. Wimmer, R. M. Rios, et al. 2003. Chlamydomonas DIP13 and human NA14: a new class of proteins associated with microtubule structures is involved in cell division. J. Cell Sci. 116: 1449–1462
   PubMed Web of Science ®Google Scholar
• Nozawa, K., K. Ikeda, M. Satoh, et al. 2009. Autoantibody to NA14 is an independent marker primarily for Sjogren's syndrome. Front. Biosci. (Landmark Ed). 14: 3733–3739
   PubMed Web of Science ®Google Scholar
• Arnett, F. C., S. M. Edworthy, D. A. Bloch, et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31: 315–324
   PubMed Web of Science ®Google Scholar
• Tan, E. M., A. S. Cohen, J. F. Fries, et al 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25: 1271–1277
   PubMed Web of Science ®Google Scholar
• Rasmussen, A., J.A. Ice, H. Li, et al. 2014. Comparison of the American-European Consensus Group Sjögren's syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort. Ann. Rheum. Dis. 73: 31–38
   PubMed Web of Science ®Google Scholar
• Varis, A., A. L. Salmela, and M. J. Kallio. 2006. Cenp-F (mitosin) is more than a mitotic marker. Chromosoma 115: 288–295
   PubMed Web of Science ®Google Scholar
• Nguyen, C. Q., and A. B. Peck. 2013. The interferon-signature of Sjögren’s syndrome: how unique biomarkers can identify underlying inflammatory and immunopathological mechanisms of specific diseases. Front. Immunol. 4: 142
   PubMed Web of Science ®Google Scholar
• Candon, S., J. E. Gottenberg, D. Bengoufa, L. Chatenoud, and X. Mariette. 2009. Quantitative assessment of antibodies to ribonucleoproteins in primary Sjögren syndrome: correlation with B-cell biomarkers and disease activity. Ann. Rheum. Dis. 68: 1208–1212
   PubMed Web of Science ®Google Scholar
• Nezos, A., A. Papageorgiou, G. Fragoulis, et al. 2014. B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren’s syndrome. J. Autoimmun. 51: 89–98
   PubMed Web of Science ®Google Scholar
• Arbuckle, M. R., M. T. McClain, M. V. Rubertone, et al. 2003. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Eng. J. Med. 349: 1526–1533
   PubMed Web of Science ®Google Scholar
• Manganelli, P., F. Quaini, A. M. Andreoli, et al. 1997. Quantitative analysis of apoptosis and bcl-2 in Sjögren's syndrome. J. Rheumatol. 24: 1552–1557
   PubMed Web of Science ®Google Scholar
• Kong, L., N. Ogawa, T. Nakabayashi, et al. 1997. Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum. 40: 87–97
   PubMed Web of Science ®Google Scholar
• Doyle, H. A., and M. J. Mamula. 2005. Posttranslational modifications of self-antigens. Ann. N. Y. Acad. Sci. 1050: 1–9
   PubMed Web of Science ®Google Scholar
• Chang, M. K., C. J. Binder, Y. I. Miller, et al. 2004. Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J. Exp. Med. 200: 1359–1370
   PubMed Web of Science ®Google Scholar
• Kanfer G., T. Courthéoux, M. Peterka, et al. 2015. Mitotic redistribution of the mitochondrial network by Miro and Cenp-F. Nat Commun. 6: 8015
   PubMed Web of Science ®Google Scholar
• Nozawa, K., M. J. Fritzler, C. A. von Mühlen, and E. K. Chan. 2004. Giantin is the major Golgi autoantigen in human anti-Golgi complex sera. Arthritis Res. Ther. 6: R95–R102
   PubMed Web of Science ®Google Scholar
• Selak, S., E. K. Chan, L. Schoenroth, et al. 1999. Early endosome antigen. 1: An autoantigen associated with neurological diseases. J. Investig. Med. 47: 311–318
   PubMed Web of Science ®Google Scholar
• Grifith, K. J., J. P. Ryan, J. L. Senécal, and M. J. Fritzler. 2002. The cytoplasmic linker protein CLIP-170 is a human autoantigen. Clin. Exp. Immunol. 127: 533–538
   PubMed Web of Science ®Google Scholar
• Doxsey, S. J., P. Stein, L. Evans, et al. 1994. Pericentrin, a highly conserved centrosome protein involved in microtubule organization. Cell 76: 639–650
   PubMed Web of Science ®Google Scholar
• Bouckson-Castaing, V., M. Moudjou, D. J. Ferguson, et al. 1996. Molecular characterisation of ninein, a new coiled-coil protein of the centrosome. J. Cell Sci. 109: 179–190
   PubMed Web of Science ®Google Scholar
• Mack, G. J., J. Rees, O. Sandblom, et al. 1998. Autoantibodies to a group of centrosomal proteins in human autoimmune sera reactive with the centrosome. Arthritis Rheum. 41: 551–558
   PubMed Web of Science ®Google Scholar
• Rattner, J. B., J. Rees, F. C. Arnett, et al. 1996. The centromere kinesin-like protein, CENP-E. An autoantigen in systemic sclerosis. Arthritis Rheum. 39: 1355–1361
   PubMed Web of Science ®Google Scholar
• Rattner, J. B., J. Rees, C. M. Whitehead, et al. 1997. High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F. Clin. Invest. Med. 20: 308–319
   PubMed Web of Science ®Google Scholar
• Hall, J. C., L. Casciola-Rosen, A. E. Berger, et al. 2012. Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases. Proc. Natl. Acad. Sci. U. S. A. 109: 17609–17614
   PubMed Web of Science ®Google Scholar
• Pelegrino, F. S., E. A. Volpe, N. B. Gandhi, et al. 2012. Deletion of interferon-γ delays onset and severity of dacryoadenitis in CD25KO mice. Arthritis Res. Ther. 14: R234
   Google Scholar
• Kimoto, O., J. Sawada, K. Shimoyama, et al. 2011. Activation of the interferon pathway in peripheral blood of patients with Sjogren’s syndrome. J. Rheumatol. 38: 310–316
   PubMed Web of Science ®Google Scholar
• Gannot, G., D. Bermudez, D. Lillibridge, and P. C. Fox. 1998. Fas and Fas-mediated effects on a human salivary cell line in vitro: a model for immune-mediated exocrine damage in Sjögren's syndrome. Cell Death Differ. 5: 743–750
   PubMed Web of Science ®Google Scholar
• Kulkarni, K., K. Selesniemi, and T. L. Brown. 2006. Interferon-gamma sensitizes the human salivary gland cell line, HSG, to tumor necrosis factor-alpha induced activation of dual apoptotic pathways. Apoptosis. 11: 2205–2215
   PubMed Web of Science ®Google Scholar
• Antonelli, A., S. M. Ferrari, D. Giuggioli, et al. 2010. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. Autoimmune Rev. 13: 272–280
   Web of Science ®Google Scholar
• Li, J., M. Y. Jeong, J. H. Bae, et al. 2010. Toll-like receptor3-mediated induction of chemokines in salivary epithelial cells. Korean J. Physiol. Pharmacol. 14: 235–240
   PubMed Web of Science ®Google Scholar
• Liu, M., S. Guo, J. M. Hibbert, et al. 2011. CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications. Cytokine Growth Factor Rev. 22: 121–130
   PubMed Web of Science ®Google Scholar
• Mackay, F., S. A. Woodstock, P. Lawton, et al. 1999. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190: 1697–1710
   PubMed Web of Science ®Google Scholar
• Nocture, G., and X. Mariette. 2013. Advances in understanding the pathogenesis of primary Sjögren's syndrome. Nat. Rev. Rheumatol. 9: 544–556
   PubMed Web of Science ®Google Scholar
• Brkic, Z., N. I. Maria, C. G. van Helden-Meeuwsen, et al. 2013. Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression. Ann. Rheum. Dis. 72: 728–735
   PubMed Web of Science ®Google Scholar
• Ittah, M., C. Miceli-Richard, J. E. Gottenberg, et al. 2008. Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependent and -independent pathways. Eur. J. Immunol. 38: 1058–1064
   PubMed Web of Science ®Google Scholar
• Mariette, X., S. Roux, J. Zhang, et al. 2003. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome. Ann. Rheum. Dis. 62: 168–171
   PubMed Web of Science ®Google Scholar
• Daridon, C., V. Devauchelle, F. Hutin, et al. 2007. Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum. 56: 1134–1144
   PubMed Web of Science ®Google Scholar
• Lavie, F., C. Miceli-Richard, M. Ittah, et al. 2008. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome. Scand. J. Immunol. 67: 185–192
   PubMed Web of Science ®Google Scholar